Photoplethysmographic Scaling of Dyspnoea (DYSPO)

Photoplethysmographic Signal Analysis as a Proxy for Excessive Effort and Impending Respiratory Failure

Timely prediction of impending respiratory failure is vital, yet relies on subjective clinical assessment of the patient's respiratory status. Pulse oximetry plethysmographic signal analysis is indicative of the effort to breathe and may provide an objective measurement of respiratory loading.

Study Overview

Status

Completed

Conditions

Detailed Description

Initiating invasive mechanical ventilation is a vital and delay-critical decision. Precise and timely prediction of impending respiratory failure would be highly consequential. Subjective evaluation of respiratory loading conditions is inconsistent, imprecise and may result in erroneous management. Photoplethysmographic (POP) waveform analysis provides a non-invasive, readily available tool to estimate breathing effort in a semiquantitative fashion.

It is the aim of this study to examine:

  1. if the degree of dyspnoea, when clinically assessed by means of the respiratory rate and SpO2 values, correlates with the SpO2 wave variations (ΔPOP) in ICU spontaneously breathing COVID-19 and non-COVID-19 patients.
  2. if a ΔPOP threshold could be identified to adequately predict further need of orotracheal intubation and invasive mechanical ventilation.

This study consists of three main steps:

  1. Clinical evaluation of dyspnoea based on:

    1.1. Respiratory rate

    1.2. Oxygen saturation (SpO2)

  2. Storage of SpO2 curve for ΔPOP computation according to a proprietary algorithm after offline POP analysis .
  3. Within a time frame of 10 days from when the first two steps are met, monitor for need of invasive ventilatory support.

Study Type

Observational

Enrollment (Actual)

60

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Bucharest, Romania, 014461
        • Clinical Emergency Hospital Bucharest
      • Bucharest, Romania, 030303
        • Clinical Hospital of Infectious and Tropical Diseases "Dr. Victor Babes"

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 70 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Spontaneously breathing ICU (COVID and non-COVID-19) adult patients with sinus rhythm, under any form of non-invasive respiratory support.

Description

Inclusion Criteria:

  • Informed consent from patient or next-of-kin according to local administrative decision
  • Spontaneous breathing, including during prone position
  • Sinus rhythm
  • Minimum standards for ICU monitoring: ECG, blood pressure (invasive or non-invasive), respiratory rate (by ECG signal), SpO2 and temperature

Exclusion Criteria:

  • Suspected pregnancy
  • Weight > 120 Kg or < 60 kg
  • Emergency or urgency
  • Intubated ( and mechanically ventilated) patient
  • Non- sinus rhythm
  • Left ventricular ejection fraction (LVEF) ≤ 30%
  • Right ventricular (RV) dysfunction ( RVEF ≤ 30% at transthoracic echocardiography (TTE))
  • Significant pulmonary hypertension (PHT) (TTE: mean pulmonary arterial pressure (mPAP) ≥ 35 mm.Hg)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Spontaneous breathing ICU non-COVID

Spontaneously breathing non-COVID-19 critically ill patients with sinus rhythm.

Inclusion and exclusion criterion are listed elsewhere.

In both groups, pulse oximeters provide continuous monitoring of oxygen saturation (SpO2).

Also, SpO2 curve can be recorded for off-line analysis.

ECG signal is used to monitor respiratory rate (RR).
Spontaneous breathing ICU COVID

Spontaneously breathing COVID-19 critically ill patients with sinus rhythm.

Inclusion and exclusion criterion are listed elsewhere.

In both groups, pulse oximeters provide continuous monitoring of oxygen saturation (SpO2).

Also, SpO2 curve can be recorded for off-line analysis.

ECG signal is used to monitor respiratory rate (RR).

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Rate of failure of spontaneous breathing
Time Frame: Day 10
Number of patients who fail spontaneous breathing (SB). Failure of SB is defined as death or need of invasive mechanical ventilation whereas SB includes any form of non-invasive ventilatory support
Day 10

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Respiratory rate
Time Frame: Day 0
Patient's respiratory rate during non-invasive respiratory support as derived from an ECG signal
Day 0
SpO2 under non-invasive respiratory support
Time Frame: Day 0
Peripheral oxygen saturation (SpO2) as measured with a pulse oximeter during any form of non-invasive ventilatory support
Day 0
ΔPOP
Time Frame: day 0
Photoplethysmographic variation index following offline computation of the SpO2 curve stored at day 0 according to a proprietary algorithm
day 0

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Serban I Bubenek Turconi, Professor, Emergency Institute for Cardiovascular Diseases Prof Dr CC Iliescu

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 1, 2020

Primary Completion (Actual)

May 30, 2021

Study Completion (Actual)

July 30, 2021

Study Registration Dates

First Submitted

October 4, 2020

First Submitted That Met QC Criteria

October 4, 2020

First Posted (Actual)

October 12, 2020

Study Record Updates

Last Update Posted (Actual)

August 3, 2021

Last Update Submitted That Met QC Criteria

August 2, 2021

Last Verified

August 1, 2021

More Information

Terms related to this study

Other Study ID Numbers

  • 18751
  • Dyspnoea - SpO2 curve study (Other Identifier: CC Iliescu Institute)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Respiratory Failure

Clinical Trials on Pulse oximeter

Subscribe